Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Novo Nordisk Slides as Forecast Boost Fails to Impress

Novo Nordisk A/S raised its forecasts for the second time this year, citing higher expectations for its obesity and diabetes drug sales, though the magnitude of the increase failed to impress investors.

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

More from Tuesday 4 August →